Siemens Aktiengesellschaft · XETR:SIE
Siemens Aktiengesellschaft — Siemens — Investor Day (February 2012)
24 slides from Siemens Aktiengesellschaft's investor day presentation, Feb 14, 2012
Slide 1: Clinical Products – Building strength in X-Ray & Ultrasound
Clinical Products – Building strength in X-Ray & Ultrasound Norbert Gaus CEO Healthcare Clinical Products Capital Market Day Siemens Healthcare London, February 14, 2012 © Siemens AG 2012. All rights reserved.
Slide 2: Safe Harbour Statement
Safe Harbour Statement This document contains forward-looking statements and information – that is, statements related to future, not past, events. These statements may be identified by words such as ―expects,‖ ―looks forward to,‖ ―anticipates,‖ ―intends,‖ ―plans,‖ ―believes,‖ ―seeks,‖ ―estimates,‖
Slide 3: Improving patient outcomes in all phases of care
Improving patient outcomes in all phases of care From early detection to therapy Prenatal Thorax X-Ray and Orthopedic Mammography Ultrasound Ultrasound X-Ray Fluoroscopy Surgery © Siemens AG 2012. All rights reserved. Page 3 February 14, 2012 Capital Market Day Healthcare Healthcare Clinical Product
Slide 4: From simple to the most sophisticated healthcare settings
From simple … to the most sophisticated healthcare settings From rural to urban areas Rural clinic in Small community County level Mid-size hospital University China hospital in Germany hospital in China in the U.S. hospital in Norway © Siemens AG 2012. All rights reserved. Page 4 February 14, 2012
Slide 5: From entry level to mid-range to the most advanced systems
From entry level … to mid-range … to the most advanced systems From entry-level to high-end systems €10k €500k Ultra- Mammo- Mobile C-Arm Ultrasound X-Ray System Ultrasound Fluoroscopy System sound graphy Polymobil X150 Multix Select DR ABVS Luminos dRF S2000 Inspiration © Siemens AG 2012. All right
Slide 6: We offer our customers a broad and innovative product portfolio
We offer our customers a broad and innovative product portfolio From early detection to therapy From rural to urban areas From entry-level to high-end systems €10k €500k © Siemens AG 2012. All rights reserved. Page 6 February 14, 2012 Capital Market Day Healthcare Healthcare Clinical Products
Slide 7: Clinical Products: A global competitor
Clinical Products: A global competitor >170,000 installed systems >13,000 systems p.a. 17 locations >8,000 employees © Siemens AG 2012. All rights reserved. Page 7 February 14, 2012 Capital Market Day Healthcare Healthcare Clinical Products
Slide 8: Steady growth will continue into the future
Steady growth will continue into the future 90% of all hospitalized patients get an X-Ray examination 70% of all imaging procedures in the U.S. are Ultrasound or X-Ray Global market for X-Ray and Ultrasound is growing by 4-5% mid-term The fastest growth is in Developed markets are still essent
Slide 9: Our growth strategy: Expand sales channels and broaden our product portfolio
Our growth strategy: Expand sales channels and broaden our product portfolio Expanding our product portfolio, esp. in mid-range and entry level Building up new sales channels to increase market coverage Expanding engineering and manufacturing in Asia Building strength in Constantly improving our cos
Slide 10: Using innovations to grow in our high-end segments
Using innovations to grow in our high-end segments … S30001) and HD transducer Luminos Agile Next-generation transducers for Addressing underutilized RF rooms in the U.S. deeper penetration Dynamic flat panel detector … and to drive new applications one system for radiography and fluoroscopy Faste
Slide 11: Expanding product portfolio for mid-range and entry-level markets
… expanding product portfolio for mid-range and entry-level markets Industry-leading reliability x5 Development and Units manufacturing in Korea X 300 PE FY2008 FY2011 Ultrasound Superior imaging performance Very price competitive Development and -30% -50% Costs Dose Multix Select DR manuf
Slide 12: Opening new customer groups: Broader sales channels
Opening new customer groups: Broader sales channels Sales through indirect channels Various clinical specialties CAGR +20% FY 2010 FY 2012E Increasing number of distributors Small clinics and private practices Example Germany +9% ~2,000 hospitals but >90,000 private practices FY 2010 New partner FY
Slide 13: Expanding our global footprint
Expanding our global footprint … Ten years ago: Main locations in developed countries Manufacturing R&D Product Management © Siemens AG 2012. All rights reserved. Page 13 February 14, 2012 Capital Market Day Healthcare Healthcare Clinical Products
Slide 14: Expanding our footprint in the emerging markets
Expanding our footprint in the emerging markets Today: 17 locations worldwide Product line competence centers in Asia China 2004 2007 2011 Start of X- Move to Entry-level Ray tube new competence production facility center X-Ray Start as 5,000th Entry-level Joint system competence Venture shipped cen
Slide 15: China and Korea: Production and engineering close to a growing customer base
China and Korea: Production and engineering close to a growing customer base China Korea Footprint in China Sales Footprint in Korea Customer proximity Highly trained engineers +36% Market size Local Ultrasound industry Low cost sourcing Low cost sourcing Low cost labor Proximity to
Slide 16: Continuous improvement of our cost position
Continuous improvement of our cost position Example Multix Select DR: Design-to- cost 30% cost reduction Clear cost reduction goals for new products Implementation of the Siemens Production System Example: Collimator Production Productivity 80% 15% lead time reduction productivity gain Continuous im
Slide 17: Components: Competitive driver across the entire Siemens Healthcare Sector
Components: Competitive driver across the entire Siemens Healthcare Sector Electronic Power- Mechatronic X-Ray tubes components electronics Component development and manufacturing for the entire Sector Fully competitive cost position across the market space © Siemens AG 2012. All rights reserved
Slide 18: Clinical Products: Broader global profile, new sales initiatives, innovative products
Clinical Products: Broader global profile, new sales initiatives, innovative products Global demand for X-Ray and Ultrasound is growing CP is widening its entry-level and high-end product range Building-up new channels to acquire new customers Increase our emerging market footprint Continu
Slide 19: Reconciliation and Definitions for Non-GAAP Measures (I)
Reconciliation and Definitions for Non-GAAP Measures (I) To supplement Siemens’ Consolidated Financial Statements presented in accordance with International Financial Reporting Standards, or IFRS, Siemens presents the following supplemental financial measures: New orders and order backlog; Adjusted
Slide 20: Reconciliation and Definitions for Non-GAAP Measures (II)
Reconciliation and Definitions for Non-GAAP Measures (II) New orders and order backlog - continued Order backlog represents an indicator for the future revenues of our Company resulting from already recognized new orders. Order backlog is calculated by adding the new orders of the current fiscal yea
Slide 21: Reconciliation and Definitions for Non-GAAP Measures (III)
Reconciliation and Definitions for Non-GAAP Measures (III) Total Sectors Profit Siemens uses Total Sectors profit to measure the sum of profit of the four Sectors Energy, Healthcare, Industry and Infrastructure & Cities. Profit of the Sectors is earnings before financing interest, certain pension co
Slide 22: Reconciliation and Definitions for Non-GAAP Measures (IV)
Reconciliation and Definitions for Non-GAAP Measures (IV) ROCE (adjusted) – continued ROCE (adjusted) at the Siemens group level on a continuing and discontinued operations basis Siemens also presents group ROCE (adjusted) on a continuing and discontinued operations basis. For this purpose, the nume
Slide 23: Reconciliation and Definitions for Non-GAAP Measures (V)
Reconciliation and Definitions for Non-GAAP Measures (V) Adjusted EBITDA, adjusted EBIT and adjusted EBITDA margins on a continuing operations basis – continued Adjusted EBITDA margins at the Sector level Siemens defines adjusted EBITDA margins at the Sector level as the ratio of adjusted EBITDA to
Slide 24: Reconciliation and Definitions for Non-GAAP Measures (VI)
Reconciliation and Definitions for Non-GAAP Measures (VI) Limitations on the usefulness of Siemens’ supplemental financial measures The supplemental financial measures reported by Siemens may be subject to limitations as analytical tools. In particular: With respect to new orders and order backlog: